Cognitive Screening for Dementia

Recommended Screening Tools

The Alzheimer's Association recommends the Mini-Cog as a time-efficient and effective cognitive screening test for dementia, taking only 2-4 minutes to administer with high sensitivity (76%) and specificity (89%) for detecting cognitive impairment 1, 2
The Mini-Cog combines three-item word recall and clock drawing test, validated in primary care settings with heterogeneous populations 1, 2, 3
The Mini-Cog is available in multiple languages, enhancing accessibility across diverse populations, and can be administered by any trained healthcare team member 1, 2
The American Academy of Family Physicians and the Alzheimer's Association endorse the use of brief cognitive assessment tools like the Mini-Cog for detecting cognitive impairment 1, 2

The Montreal Cognitive Assessment (MoCA) takes 10-15 minutes to administer and has higher sensitivity for detecting MCI (90%) compared to MMSE, assessing multiple cognitive domains more comprehensively 2, 3, 4
The Mini-Mental State Examination (MMSE) takes 7-10 minutes to administer, but has limited effectiveness for detecting MCI in early stages and is subject to copyright restrictions and user fees 2, 3, 5

Routine use of brief cognitive assessment tools can increase detection of cognitive impairment by two to threefold compared to unaided detection, according to the American College of Physicians 6
The American Academy of Neurology recommends considering patient's education level and language, need for detection of MCI versus dementia, and availability of an informant when choosing a cognitive screening tool 1, 3, 6
Scores on any assessment are not a diagnosis by themselves and must be interpreted in the context of a comprehensive evaluation, including medical history, neuropsychiatric assessment, and laboratory testing, as recommended by the American Geriatrics Society 6, 4

A positive Mini-Cog result should trigger a more comprehensive cognitive evaluation, including assessment of functional status and activities of daily living, evaluation for neuropsychiatric symptoms, medical history and physical examination, and laboratory testing to rule out metabolic, infectious, or other medical causes, as recommended by the Alzheimer's Association 7
The Mini-Cog has demonstrated high sensitivity and specificity for detecting cognitive impairment, with more elaborate scoring systems improving diagnostic accuracy, and an area under the curve (AUC) of 0.82 for mild cognitive impairment and 0.95 for Alzheimer's disease 7
Follow-up assessment after a positive screening result should include comprehensive cognitive testing using instruments like the Montreal Cognitive Assessment (MoCA) or Mini-Mental State Examination (MMSE), with a strength of evidence level of moderate to high 8
If cognitive impairment is confirmed, patients should be evaluated for type and severity of dementia using standardized diagnostic criteria, presence of comorbid conditions, and safety concerns, including driving and medication management, with a high level of evidence supporting the importance of comprehensive evaluation 9
Combining the Mini-Cog with functional screens and informant reports may improve case-finding in people with cognitive difficulties, with a moderate level of evidence supporting this approach 7

The Alzheimer's Association recommends the Mini-Cog for cognitive screening during Medicare Annual Wellness Visits, with a high level of evidence supporting its use 10
Early detection of cognitive impairment can facilitate timely intervention, care planning, and caregiver support, with a moderate to high level of evidence supporting the benefits of early detection 9, 11